Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
20-Jun-2018Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME studyAnzueto, AR; Kostikas, K; Mezzi, K; Shen, S; Larbig, M, et al
18-Oct-2018Reply to: Different background, short duration, inappropriate participants may harm your conclusionChapman, KR; Hurst, JR; Fogel, RB; Pfister, P; Kostikas, K, et al
20-May-2018Long-term triple therapy de-escalation to indacaterol/glycopyrronium in COPD patients (SUNSET): a randomized, double-blind, triple-dummy clinical trialChapman, KR; Hurst, JR; Frent, S; Larbig, M; Fogel, R, et al
9-Aug-2018Single-inhaler triple versus dual therapy in patients with COPDWedzicha, JA; Banerji, D; Kostikas, K
10-Apr-2018Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME studyVogelmeier, CF; Chapman, KR; Miravitlles, M; Roche, N; Vestbo, J, et al
18-Jul-2018Capturing Exacerbations of Chronic Obstructive Pulmonary Disease with EXACT: A Sub-Analysis of FLAMEFrent, SM; Chapman, KR; Larbig, M; Mackay, A; Fogel, R, et al
8-Jan-2019Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME studyWedzicha, JA; Singh, D; Tsiligianni, I; Jenkins, C; Fucile, S, et al
6-Dec-2016How Do Dual Long-Acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?Beeh, KM; Burgel, P-R; Franssen, FME; Luis Lopez-Campos, J; Loukides, S, et al
15-Sep-2018Patient reported outcomes for the detection, quantification and evaluation of chronic obstructive pulmonary disease exacerbationsMackay, AJ; Kostikas, K; Murray, L; Martinez, FJ; Miravitlles, M, et al